P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rajesh Belani, M.D.
Sponsor Executive Medical Director
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- University of California Davis
Davis, California, United States
- University of California San Diego
San Diego, California, United States
- University of California San Francisco
San Francisco, California, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- University of Chicago
Chicago, Illinois, United States
- University of Kansas Cancer Center
Westwood, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, United States
- Wayne State - Karmanos Cancer Institute
Detroit, Michigan, United States
- John Theurer Cancer Center
Hackensack, New Jersey, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute at Tennessee Oncology
Nashville, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Swedish Cancer Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Sept 2017
- Primary completion
- 27 Apr 2022
- Completion
- 27 Apr 2022
- Last update posted
- 28 Mar 2024
- Registered enrollment
- 105
- Registry id
- NCT03288493
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.